Full Press Release Details
TARRYTOWN, N.Y.,Feb. 28, 2012/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) will webcast management presentations at the following investor conferences:
• Cowen and Company 32nd Annual Healthcare Conference at10:40 a.m. Eastern TimeonTuesday, March 6, 2012
• Barclays Capital 2012 Global Healthcare Conference at3:45 p.m. Eastern TimeonWednesday, March 14, 2012
The sessions may be accessed through the Company's web site,www.regeneron.com, on the Events and Presentations page. Archived versions of the presentations will be available for thirty days after the live webcasts.
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets two products inthe United States, one for the treatment of neovascular (wet) age-related macular degeneration and another for the treatment of a rare inflammatory condition. Additionally, Regeneron has three regulatory applications pending before the U.S. Food and Drug Administration (FDA) and 10 drug candidates in clinical development. More information and recent news releases are available on the Regeneron web site atwww.regeneron.com.
| Contact Information: | |
| Manisha Narasimhan, Ph.D. | Peter Dworkin |
| Investor Relations | Corporate Communications |
| 914-847-5126 | 914.847.7640 |
| [email protected] | [email protected] |